$106.38
0.23%
NYSE, Jan 02, 10:00 pm CET

Encompass Health Corporation Stock price

$106.37
-7.49 6.58% 1M
-12.51 10.52% 6M
+0.23 0.22% YTD
+14.52 15.81% 1Y
+46.56 77.85% 3Y
+40.90 62.48% 5Y
+78.80 285.88% 10Y
+86.89 446.05% 20Y
NYSE, Closing price Fri, Jan 02 2026
+0.23 0.22%

Key metrics

Basic
Market capitalization
$10.7b
Enterprise Value
$13.1b
Net debt
$2.4b
Cash
$82.8m
Shares outstanding
100.6m
Valuation (TTM | estimate)
P/E
20.1 | 19.9
P/S
1.8 | 1.8
EV/Sales
2.3 | 2.2
EV/FCF
32.4
P/B
4.5
Dividends
DPS
$0.70
Yield 1Y | 5Y
0.7% | 0.9%
Growth 1Y | 5Y
48.9% | -4.7%
Payout 1Y | 3Y
10.6% | 17.7%
Increased
1 Year
Financials (TTM | estimate)
Revenue
$5.8b | $6.0b
EBITDA
$1.3b | $1.3b
EBIT
$1.0b | $972.2m
Net Income
$539.1m | $538.9m
Free Cash Flow
$402.6m
Growth (TTM | estimate)
Revenue
11.1% | 11.5%
EBITDA
18.6% | 7.9%
EBIT
21.9% | 12.5%
Net Income
28.5% | 19.0%
Free Cash Flow
55.7%
Margin (TTM | estimate)
Gross
95.7%
EBITDA
22.8% | 21.0%
EBIT
17.3%
Net
9.3% | 9.0%
Free Cash Flow
7.0%
Financial Health
Equity Ratio
31.6%
Return on Equity
21.9%
ROCE
16.4%
ROIC
-
Debt/Equity
1.0
More
EPS
$5.3
FCF per Share
$4.0
Short interest
3.3%
Employees
25k
Rev per Employee
$210.0k
Show more

Is Encompass Health Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Encompass Health Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Encompass Health Corporation forecast:

16x Buy
94%
1x Hold
6%

Analyst Opinions

17 Analysts have issued a Encompass Health Corporation forecast:

Buy
94%
Hold
6%

Financial data from Encompass Health Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
5,796 5,796
11% 11%
100%
- Direct Costs 252 252
7% 7%
4%
5,543 5,543
11% 11%
96%
- Selling and Administrative Expenses 3,353 3,353
9% 9%
58%
- Research and Development Expense - -
-
-
1,322 1,322
19% 19%
23%
- Depreciation and Amortization 320 320
10% 10%
6%
EBIT (Operating Income) EBIT 1,002 1,002
22% 22%
17%
Net Profit 539 539
29% 29%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Encompass Health Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Encompass Health Corporation Stock News

Neutral
PRNewsWire
about one month ago
BIRMINGHAM, Ala. and LAKE WORTH, Fla.
Neutral
PRNewsWire
about one month ago
BIRMINGHAM, Ala. and FISHERS, Ind.
More Encompass Health Corporation News

Company Profile

Encompass Health Corp. engages in providing post-acute healthcare services. It operates through the following segments: Inpatient Rehabilitation and Home Health & Hospice. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac & pulmonary conditions, brain & spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.

Head office United States
CEO Mark Tarr
Employees 25,191
Founded 1984
Website www.encompasshealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today